TA
Tiedemann Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $313K | Hold |
380
| – | – | 0.01% | 213 |
|
|
2023
Q2 | $273K | Sell |
380
-4
| -1% | -$2.87K | 0.01% | 211 |
|
|
2023
Q1 | $316K | Sell |
384
-5
| -1% | -$4.11K | 0.01% | 199 |
|
|
2022
Q4 | $281K | Buy |
389
+9
| +2% | +$6.49K | 0.01% | 201 |
|
|
2022
Q3 | $262K | Hold |
380
| – | – | 0.02% | 192 |
|
|
2022
Q2 | $225K | Sell |
380
-8
| -2% | -$4.74K | 0.02% | 201 |
|
|
2022
Q1 | $271K | Buy |
388
+8
| +2% | +$5.59K | 0.01% | 239 |
|
|
2021
Q4 | $240K | Hold |
380
| – | – | 0.01% | 255 |
|
|
2021
Q3 | $230K | Sell |
380
-20
| -5% | -$12.1K | 0.01% | 268 |
|
|
2021
Q2 | $224K | Sell |
400
-27
| -6% | -$15.1K | 0.01% | 334 |
|
|
2021
Q1 | $201K | Buy |
427
+13
| +3% | +$6.12K | 0.01% | 318 |
|
|
2020
Q4 | $200K | Sell |
414
-394
| -49% | -$190K | 0.01% | 306 |
|
|
2020
Q3 | $453K | Sell |
808
-34
| -4% | -$19.1K | 0.02% | 231 |
|
|
2020
Q2 | $524K | Sell |
842
-56
| -6% | -$34.9K | 0.03% | 210 |
|
|
2020
Q1 | $438K | Buy |
898
+103
| +13% | +$50.2K | 0.03% | 212 |
|
|
2019
Q4 | $299K | Sell |
795
-22
| -3% | -$8.27K | 0.01% | 245 |
|
|
2019
Q3 | $226K | Buy |
817
+122
| +18% | +$33.7K | 0.01% | 283 |
|
|
2019
Q2 | $218K | Sell |
695
-476
| -41% | -$149K | 0.01% | 274 |
|
|
2019
Q1 | $480K | Buy |
1,171
+135
| +13% | +$55.3K | 0.02% | 305 |
|
|
2018
Q4 | $387K | Buy |
1,036
+323
| +45% | +$121K | 0.02% | 323 |
|
|
2018
Q3 | $288K | Buy |
713
+18
| +3% | +$7.27K | 0.02% | 262 |
|
|
2018
Q2 | $240K | Buy |
+695
| New | +$240K | 0.02% | 268 |
|